US Stock MarketDetailed Quotes
AMPH Amphastar Pharmaceuticals
- 39.140
- -0.250-0.63%
Close Dec 20 16:00 ET
- 39.140
- 0.0000.00%
Post 19:54 ET
1.88BMarket Cap13.00P/E (TTM)
40.740High38.960Low2.48MVolume39.310Open39.390Pre Close97.69MTurnover6.65%Turnover Ratio15.05P/E (Static)48.08MShares65.92552wk High2.59P/B1.46BFloat Cap36.56052wk Low--Dividend TTM37.35MShs Float67.660Historical High--Div YieldTTM4.52%Amplitude6.670Historical Low39.311Avg Price1Lot Size
Amphastar Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.80%59.96M | 25.83%69.11M | 36.92%55.29M | 105.76%183.5M | 56.73%23.86M | 215.75%64.33M | 1,851.08%54.92M | -20.45%40.38M | -8.99%89.18M | -62.35%15.23M |
| Net income from continuing operations | -17.86%40.43M | 45.26%37.95M | 65.86%43.18M | 50.51%137.55M | 6.65%36.17M | 210.08%49.22M | 50.61%26.12M | 7.34%26.03M | 44.37%91.39M | 71.62%33.91M |
| Operating gains losses | 334.48%6.09M | -93.56%164K | -514.66%-4.07M | 986.79%7.79M | 933.94%6.86M | -295.13%-2.6M | -12.54%2.55M | 142.53%982K | 93.25%-878K | -48.11%-822K |
| Depreciation and amortization | 6.35%14.43M | 101.47%14.15M | 88.79%13.96M | 47.75%41.78M | 88.22%13.79M | 85.27%13.57M | 2.81%7.02M | 8.84%7.4M | 6.57%28.28M | 15.70%7.33M |
| Deferred tax | ---- | ---- | ---- | 12.79%-13.74M | ---- | ---- | ---- | ---- | -474.22%-15.75M | ---- |
| Other non cash items | -85.79%744K | -23.64%2.44M | 3,506.78%2.13M | 2,346.14%11.4M | 9,610.00%2.91M | 2,046.31%5.24M | --3.19M | --59K | 112.79%466K | --30K |
| Change In working capital | -27.56%-7.33M | 1.85%8.64M | -3,569.19%-7.27M | 24.76%-24.21M | -94.17%-26.75M | 14.40%-5.74M | 129.54%8.48M | -101.16%-198K | -1,549.26%-32.18M | -216.77%-13.77M |
| -Change in receivables | 58.99%-8.06M | 428.82%6.68M | -96.69%-23.2M | -157.46%-26.09M | 135.39%4.09M | -645.46%-19.64M | 116.24%1.26M | -310.72%-11.8M | 32.10%-10.13M | -1,430.46%-11.56M |
| -Change in inventory | -26.67%-7.31M | -578.74%-7.03M | -3,829.48%-10M | 85.32%-1.72M | 309.27%4.81M | -4.91%-5.77M | 78.14%-1.04M | 109.97%268K | -1,033.70%-11.75M | -83.26%1.18M |
| -Change in prepaid assets | -1,589.76%-10.73M | -16.89%433K | -187.67%-192K | -47.14%-2.73M | 11.36%-2.83M | -172.65%-635K | 154.73%521K | -84.58%219K | -163.34%-1.85M | -282.32%-3.2M |
| -Change in payables and accrued expense | 208.02%24.65M | 341.46%13.73M | 318.53%23.08M | 1,898.51%13.24M | 75.06%-3.39M | 2,803.38%8M | -15.97%3.11M | -41.60%5.51M | -120.25%-736K | -1,162.27%-13.58M |
| -Change in other current liabilities | -5.56%-968K | -7.09%-951K | -9.86%-947K | -13.79%-3.59M | -8.34%-922K | -9.82%-917K | -14.88%-888K | -24.03%-862K | 1.38%-3.15M | -27.20%-851K |
| -Change in other working capital | -137.17%-4.91M | -176.72%-4.23M | -38.19%3.99M | 27.14%-3.32M | -300.25%-28.5M | 390.25%13.22M | 130.33%5.51M | 64.52%6.46M | -154.56%-4.56M | 158.00%14.23M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.80%59.96M | 25.83%69.11M | 36.92%55.29M | 105.76%183.5M | 56.73%23.86M | 215.75%64.33M | 1,851.08%54.92M | -20.45%40.38M | -8.99%89.18M | -62.35%15.23M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -11.02%-34.59M | 86.26%-69.9M | 340.60%15.24M | -1,880.40%-649.12M | -44,899.56%-103.05M | -104.17%-31.15M | -6,117.38%-508.58M | 30.48%-6.33M | -14.32%-32.78M | 98.08%-229K |
| Net PPE purchase and sale | -35.32%-13.79M | 33.24%-6.04M | 7.22%-8.79M | -61.63%-38.17M | -49.64%-9.44M | -81.27%-10.19M | -63.40%-9.05M | -54.37%-9.48M | 14.00%-23.61M | 8.26%-6.31M |
| Net business purchase and sale | --0 | ---- | ---- | ---506.41M | --0 | ---5.58M | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | -1.85%-19.74M | 2,888.67%66.74M | 664.31%24.03M | -1,259.52%-105.93M | -1,357.46%-91.93M | -104.19%-19.38M | 178.88%2.23M | 213.01%3.14M | -658.17%-7.79M | 304.90%7.31M |
| Net other investing changes | -126.45%-1.06M | ---- | ---- | 201.31%1.39M | -36.10%-1.67M | 2,855.86%4M | ---- | ---- | 47.47%-1.37M | 18.44%-1.23M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -11.02%-34.59M | 86.26%-69.9M | 340.60%15.24M | -1,880.40%-649.12M | -44,899.56%-103.05M | -104.17%-31.15M | -6,117.38%-508.58M | 30.48%-6.33M | -14.32%-32.78M | 98.08%-229K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -126.34%-22.82M | -102.50%-10.72M | -0.23%-13.58M | 1,817.51%454.09M | -191.31%-47.08M | 721.72%86.61M | 43,169.52%428.11M | -391.48%-13.55M | 28.58%-26.44M | -85.86%-16.16M |
| Net issuance payments of debt | -93.47%9.47M | -101.86%-8.03M | 511.57%3.98M | 29,653.17%526.34M | -39,081.25%-50.15M | 27,863.60%144.93M | 73,040.30%432.54M | -79.93%-968K | -105.55%-1.78M | 79.12%-128K |
| Net common stock issuance | 30.09%-34.96M | -6,539.06%-8.5M | --0 | -45.69%-58.14M | --0 | -244.98%-50M | 97.91%-128K | -552.16%-8.02M | -38.22%-39.91M | -34.48%-18.07M |
| Proceeds from stock option exercised by employees | 53.43%3.26M | -40.98%5.82M | -279.21%-17.31M | -29.91%10.97M | 74.68%3.56M | 51.86%2.13M | 70.38%9.85M | -170.92%-4.57M | -1.68%15.66M | -64.00%2.04M |
| Net other financing activities | 94.38%-587K | --1K | ---252K | -6,061.92%-25.08M | -16,266.67%-491K | -3,213.65%-10.44M | ---- | ---- | 99.28%-407K | 99.03%-3K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -126.34%-22.82M | -102.50%-10.72M | -0.23%-13.58M | 1,817.51%454.09M | -191.32%-47.08M | 721.73%86.61M | 43,169.52%428.11M | -391.48%-13.55M | 28.58%-26.44M | -85.86%-16.16M |
| Net cash flow | ||||||||||
| Beginning cash position | 25.50%189.85M | 13.87%201.38M | -7.55%144.53M | 23.50%156.33M | 72.11%271.04M | -9.08%151.28M | 2.31%176.85M | 23.50%156.33M | 33.95%126.59M | 47.39%157.48M |
| Current changes in cash | -97.86%2.56M | 54.95%-11.51M | 177.79%56.95M | -138.44%-11.52M | -10,738.45%-126.27M | 1,459.14%119.8M | -301.76%-25.55M | -55.72%20.5M | -7.24%29.97M | -105.89%-1.17M |
| Effect of exchange rate changes | -65.79%-63K | 13.64%-19K | -706.25%-97K | -28.18%-282K | -1,352.63%-238K | 61.62%-38K | 80.18%-22K | 155.17%16K | 1.35%-220K | 139.58%19K |
| End cash Position | -29.03%192.35M | 25.50%189.85M | 13.87%201.38M | -7.55%144.53M | -7.55%144.53M | 72.11%271.04M | -9.08%151.28M | 2.31%176.85M | 23.50%156.33M | 23.50%156.33M |
| Free cash flow | -14.72%46.17M | 37.49%63.07M | 50.45%46.5M | 123.09%145.34M | 61.75%14.42M | 267.01%54.14M | 1,557.55%45.87M | -30.75%30.91M | -7.64%65.15M | -73.44%8.92M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data